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Abstract
Background The EQ-5D is a widely used preference-based
instrument to measure health-related quality of life. Some
methodological drawbacks of its three-level version (EQ-
5D-3L) prompted development of a new format (EQ-5D-
5L). There is no clear evidence that the new format out-
performs the standard version.
Objective The objective of this study was to make a head-
to-head comparison of the EQ-5D-3L and EQ-5D-5L in a
discrete choice model setting giving special attention to the
consistency and logical ordering of coefficients for the
attribute levels and to the differences in health-state values.
Methods Using efficient designs, 240 pairs of EQ-5D-3L
health states and 240 pairs of EQ-5D-5L health states were
generated in a pairwise choice format. The study included
3698 Dutch general population respondents, analyzed their
responses using a conditional logit model, and compared
the values elicited by EQ-5D-3L and EQ-5D-5L for dif-
ferent health states.
Results No inconsistencies or illogical ordering of level
coefficients were observed in either version. The propor-
tion of severe health states with low values was higher in
the EQ-5D-5L than in the EQ-5D-3L, and the proportion of
mild/moderate states was lower in the EQ-5D-5L than in
the EQ-5D-3L. Moreover, differences were observed in the
relative weights of the attributes.
Conclusion Overall distribution of health-state values
derived from a large representative sample using the same
measurement framework for both versions showed differ-
ences between the EQ-5D-3L and EQ-5D-5L. However,
even small differences in the phrasing (language) of the
descriptive system or in the valuation protocol can produce
differences in values between these two versions.
Key Points for Decision Makers
Changes in phrasing and the use of a different
valuation protocol, in combination with particular
statistical models used to estimate the weights for the
EQ-5D attributes, may explain the discrepancies
between the 3L and 5L observed in earlier studies.
No inconsistencies or illogical ordering of level
coefficients were observed for the EQ-5D-3L or for
the EQ-5D-5L.
Differences in weights for the five EQ-5D health
attributes have been observed: the highest weight for
the EQ-5D-5L was for anxiety/depression; for the
EQ-5D-3L, it was mobility.
1 Introduction
Generic preference-based measures of health-related qual-
ity of life are frequently used to assess the impact of
treatment or clinical pathways and to monitor population
health [1–3]. Typically, preference-based measurement
frameworks incorporate various independent attributes
(notated for domains/dimensions) that jointly represent the
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notion of health-related quality of life. The levels of these
attributes are weighted to indicate the relative importance
attributed to them by the respondents (expressed prefer-
ences). Weighted attribute levels are subsequently aggre-
gated into a single number reflecting the quality or value of
a health state [4]. To obtain such values, several instru-
ments (e.g., EQ-5D, HUI-3, SF-6D, AQol) have been
developed within a preference-based measurement
framework.
The EuroQol Group (http://www.euroqol.org) devel-
oped the EQ-5D, a relatively simple, widely used instru-
ment [5–9]. It comprises five health attributes in the
descriptive system (mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression) and a 20-cm
visual analog scale. In the standard version (EQ-5D-3L),
each of the attributes can take on three levels [10]. A
considerable body of literature corroborates the sustain-
ability of the instrument [11–15]. However, attention has
been drawn to its limited sensitivity regarding small or
moderate changes in patients’ health states [16–19] and its
considerable ceiling effects (i.e., almost no differentiation
between mild health states), prompting an update of the
instrument [20–23]. In the new version, the EQ-5D-5L, the
number of levels used to classify health states increased
from three to five. Testing its descriptive system perfor-
mance in terms of its discriminatory power and sensitivity
revealed a lower ceiling effect and a higher sensitivity
[13, 19, 23–25]. Additionally, several studies noted that
subtle differences in the phrasing of levels 4 (severe
problems) and 5 (extreme problems) caused inconsistencies
in elicited health-state values [26, 27].
Besides increasing the number of levels from three to
five, the protocol to derive valuations was changed. For the
EQ-5D-3L valuation protocol, originally the time trade-off
(TTO) was chosen from among all possible health valua-
tion techniques (standard gamble, TTO, rating/visual ana-
log scale, person trade-off, and magnitude estimation).
However, various shortcomings of this technique were
identified [28–31], which encouraged the EuroQol Group
to experiment with other methods, such as choice-based
modeling. Choice models are grounded in modern mea-
surement theory and are consistent with the random utility
model in economic theory [32]. The applicability of choice
models for health-state evaluations has been proposed and
tested elsewhere [4, 33–35].
The association between the descriptive systems for the
three- and five-level versions of the EQ-5D has been
investigated extensively. Far less is known about the dis-
tribution of the values and the underlying weights for the
levels of the attributes for both EQ-5D versions, which
motivated the present study. This article presents a discrete
choice (DC) study and a head-to-head comparison of the
EQ-5D-3L and EQ-5D-5L with an emphasis on the
consistency and logical ordering of attribute levels and the
distributions of the estimated values.
2 Methods
2.1 Sample
Overall, 4036 persons participated in a self-completed
computer-based assessment by Survey Sampling Interna-
tional (SSI) [Rotterdam, the Netherlands]. The sample is
representative of age and sex for the general Dutch popu-
lation based on the SSI panel of a working age of
18–65 years and recruitment during September–October
2016. Clear instructions were given to all participants, and
those who fully completed the survey received a small
financial compensation from SSI. The rewards were
defined by the company’s (SSI) internal agreements indi-
vidually with the groups of respondents. Each one was
randomly assigned to one of the 30 blocks of the survey.
No limits on time for completion were imposed.
2.2 Discrete Choice
Discrete choice modeling is a widely used technique to
elicit personal and societal preferences in health-valuation
studies [36]. The statistical literature classifies it within the
modern framework of probabilistic DC models that are
consistent with economic theory (i.e., the random utility
model) [32, 37, 38]. All DC models establish the relative
merit of one phenomenon based on its relative attractive-
ness. This technique requires participants to make choices
among two or more presented scenarios (choice tasks)
described by the means of specific attributes with certain
levels.
2.3 Experimental Design and Selection of Health
States
The EQ-5D-3L contains five attributes with three levels
each, yielding 35 = 243 possible health states. Health states
were presented in pairs for comparison in the DC task.
Thus, the number of potential pairs to be compared
becomes 29,403. For EQ-5D-5L, the number of possible
health states increases to 55 = 3125, and the number of
possible paired comparisons rises drastically to 4,881,250.
Clearly, it is infeasible to present all possible pairs to the
respondents, especially in the case of EQ-5D-5L. For both
versions, therefore, health-state pairs had to be carefully
selected to arrive at an informative set. Two important
issues were taken into consideration in the selection:
respondent fatigue and avoidance of dominance in the
pairs.
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The credibility of an individual’s responses can be
questionable when a person gets bored or fatigued, which
could happen if the tasks are complex or numerous. Earlier
studies suggested that up to 16 choice tasks are accept-
able and do not affect the responses [31, 39, 40]. We
offered each respondent a set of 16 choice tasks and
reduced their complexity through a two-level overlap in the
health-state descriptions for both versions of the EQ-5D. A
two-level overlap implies fixing two of the five attributes at
the same level and varying the other three.
Dominance is a common difficulty in health-state val-
uation exercises because all attributes are ordered, and
people always prefer fewer health problems to more.
Dominant pairs do not offer additional information, yet
they reduce design efficiency. Therefore, it was decided to
remove all combinations where every attribute of one
health state in a pair was worse or the same (or better or the
same) than every attribute of the other health state.
In view of the above solutions for the issues of fatigue
and dominance, an approach to health-state selection was
developed along similar lines, as set forth below for the
EQ-5D-3L and the EQ-5D-5L. The set of non-dominant
pairs for EQ-5D-3L was selected out of all possible 29,403
pairs, arriving at 14,580 pairs. Likewise, in EQ-5D-5L, the
number of non-dominant pairs was reduced from 4,881,250
to 1,430,000 (Stata 14.0; StataCorp LLC, College Station,
Texas, USA). Out of all non-dominant health-state pairs
with a two-level overlap, we decided to select 240 pairs,
which is considered sufficient to estimate regression coef-
ficients for EQ-5D-5L attribute levels. It was decided to
select the same number of pairs for the EQ-5D-3L.
Therefore, 240 pairs in EQ-5D-5L and 240 pairs in EQ-5D-
3L format were selected, using an efficient design routine
programmed in Ngene software (ChoiceMetrics, Sydney,
Australia) (the mnl model, taking 500 Bayesian draws,
Halton sequence, modified Fedorov algorithm). All selec-
ted pairs were divided into 30 blocks with 16 choice tasks
each, whereby 15 blocks contained all 16 tasks in EQ-5D-
3L, and 15 blocks contained 16 tasks in EQ-5D-5L. The
design was based on an iterative procedure, where designs
are compared by their D-error (measure of statistical effi-
ciency). After numerous iterations, the designs were
checked for their D-errors and for the level balance. Level
balance ensures all levels of all attributes appear with even
frequency in the design. A perfectly even frequency of
level balance can rarely be achieved; therefore, the fairly
even distribution of levels was accepted. Finally, the design
with the lowest D-error and better indicator of level bal-
ance was chosen. Efficient design in Ngene requires priors
(approximations of the parameters), which were derived
from an earlier EQ-5D-3L study [36] and from a multi-
national study of the EQ-5D-5L [4].
2.4 Response Tasks
The response task included two health-state descriptions
comprising five attributes of the EQ-5D. The respondents
had to decide which of the two health-state descriptions
they preferred. Half of the blocks contained health-state
descriptions defined by three levels of EQ-5D-3L (no
problems, some problems, extreme problems), and half of
the blocks contained health-state descriptions defined by
five levels of EQ-5D-5L (no problems, slight problems,
moderate problems, severe problems, extreme problems).
The respondents were randomly assigned to one of the
blocks, meaning that each person completed 16 response
tasks only in the EQ-5D-3L format or (in the other block)
only in the EQ-5D-5L format.
2.5 Analysis
2.5.1 EQ-5D-3L and EQ-5D-5L Values and Value’
Distributions
The analysis of the data was performed using a DC con-
ditional logit model (asclogit, Stata 15.0; StataCorp LLC,
College Station, Texas, USA), which yields parameter
estimates presented as regression coefficients. The main-
effects value function included ten dummy variables for the
EQ-5D-3L representing levels 2 and 3 for each of the five
attributes: mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression. The main-effects model
for the EQ-5D-5L included 20 dummy variables repre-
senting levels 2, 3, 4, and 5. The regression coefficients
were checked for logical ordering and significance. In
addition, we tested for the increments from one level to any
other consecutive levels (post-hoc estimation, contrast,
Stata SE 15.0; StataCorp LLC, College Station, Texas,
USA) [41, 42].
Additionally, the values of all health states possible in
EQ-5D-3L and EQ-5D-5L were calculated based on esti-
mated coefficients. We used the original values derived
with the choice model and rescaled them to the published
results of the Dutch valuation studies for the 3L version
and 5L version, respectively [43, 44]. For the EQ-5D-3L,
the value range from the valuation studies was - 0.33 to
1.0, while for the EQ-5D-5L the value range was - 0.45 to
1.0. Finally, for both versions, the distributions of esti-
mated values were compared. Kernel density graph and
graphs of frequency distributions were produced for the
EQ-5D-3L and the EQ-5D-5L (Stata SE 15.0). For com-
parison of value ranges in both graphs for EQ-5D-3L and
the EQ-5D-5L, we provided distributions displaying the
unscaled values and the values scaled to the Dutch tariffs.
Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values 717
2.5.2 Comparison of Differences in Weights for Health-
State Attributes
The overall weights of each of the five EQ-5D attributes
were calculated using the coefficient range method: the
range between the coefficients of the individual levels was
calculated and then converted to a proportion.
Wattribute ið Þ ¼ maxCi minCiP
jðmaxCj minCjÞ
; ð1Þ
where Ci represents the coefficients of the individual levels
of attribute i and j represents the number of attributes.
3 Results
3.1 Sample
In total, 4036 respondents completed the survey. Out of
this sample, 288 completed 16 choice tasks in less than 2
min, which was considered unrealistic and insufficient. In
addition, responses of 50 individuals were deemed unreli-
able, given their pattern of choosing only the left (A) or
only the right (B) alternative throughout the survey.
Therefore, the forms of 338 respondents were disregarded.
Finally, the analysis included 1824 respondents for the EQ-
5D-3L and 1874 for the EQ-5D-5L (Table 1). An overall
Chi-square test revealed significant differences between the
samples completing EQ-5D-3L and EQ-5D-5L in terms of
age groups: p = 0.000.
3.2 Comparison of EQ-5D-3L and EQ-5D-5L
Coefficients and Overall Attribute Weights
No inconsistencies or illogical ordering of level coeffi-
cients were observed for the 3L and 5L versions. The
spread of regression coefficients within each attribute
consistently followed the same patterns across attributes:
levels 2 and 3 lowered the values slightly, levels 4 and 5
even more so in the EQ-5D-5L. Moreover, the incremental
differences between consecutive levels of each dimension
were checked for significance, whereby it was observed
that the move from level 5 to level 4 of severity had a
smaller effect than the move from level 4 to level 3. All
parameters in both models were statistically significant
(Tables 2, 3).
Self-care was generally assigned less weight than the
other four attributes in the EQ-5D-3L and in EQ-5D-5L
(Table 2). Moreover, level 3 problems with mobility
(confined to bed) appeared to have the largest effect on the
values in the EQ-5D-3L format. Overall, the attribute
mobility in the EQ-5D-3L version was assigned the highest
relative weight. Regarding the EQ-5D-5L version, the
respondents were more concerned about anxiety/depression
and pain/discomfort than about problems with other attri-
butes. Regarding the EQ-5D-3L version, we noted that
pain/discomfort had more relative weight than anxiety/
depression, while the opposite was noted for EQ-5D-5L.
3.3 Comparison of EQ-5D-3L and EQ-5D-5L Value
Distributions
The original unscaled values of both EQ-5D versions were
anchored to the values of the best and worst health states
derived from the Dutch valuation studies [43, 44], and
plotted as the frequency distribution of estimated values for
243 health states in the EQ-5D-3L and 3125 health states in
the EQ-5D-5L (Fig. 1). The graph demonstrates that the
distributions of values elicited with unscaled coefficients
are similar to the distribution of the rescaled values because
only the scale is changed, not the distribution of the values.
These graphs and the kernel density graph (Fig. 2)
demonstrate that EQ-5D-5L has more health states than
EQ-5D-3L on the region with severe health states and
fewer states on the region with milder states.
4 Discussion
4.1 Overall Discussion and Literature Review
This study contributes to the body of literature comparing
the standard EQ-5D-3L and the new EQ-5D-5L. Here, the
focus is on the logical ordering and differences in distri-
butions of values for health states in these two versions.
The health-state values were elicited from a sample of the
general population applying a conventional DC approach.
According to several earlier studies, the differences in EQ-
5D-5L levels are subtle and may be hard to distinguish,
which might have caused inconsistencies for some lan-
guage versions (English) in the upper or lower levels of
health attributes [26, 27, 44]. Eventually, such inconsis-
tency would affect the validity of the estimated values. In
the current Dutch study, we found that all coefficients for
both versions of EQ-5D were logically ordered.
However, the results demonstrated that the overall
weights for the attributes are different in the two EQ-5D
versions. In the EQ-5D-5L, the highest weight was attrib-
uted to anxiety/depression followed by pain/discomfort; in
the EQ-5D-3L, the highest weight was attributed to
mobility. Larger weights of an attribute have larger effects
on a health-state value: the negative changes in the levels
of the most important attributes could overweigh the pos-
itive changes in the levels of the less important attributes,
resulting in lower values.
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Mobility, especially level 3 (confined to bed), had the
most significant impact in the EQ-5D-3L. It is clear that
‘confined to bed’ has a different phrasing format for level 3
than it has in the other attributes. In later versions of the
EQ-5D, namely the version for youth (EQ-5D-Y) and the
EQ-5D-5L, the formulation of the worst levels was chan-
ged into ‘unable to walk’ [19, 44–47]. In the EQ-5D-5L
version, with the most severe level formulated as ‘unable
to’, the effect of mobility on the health-state values
declined. Changing the phrasing from ‘confined to bed’ to
‘unable to walk’ is likely responsible for the shift in the
level of importance. ‘Confined to bed’ seems to imply
isolation and dependence, while ‘unable to walk’ may be
interpreted as a less serious limitation.
A large multinational study based on DC modeling for
the EQ-5D-5L [4] showed greater importance assigned to
pain/discomfort and anxiety/depression attributes for the
Dutch population, while for the US population the attribute
mobility had the greater importance. The Dutch valuation
study for the EQ-5D-5L confirmed that the greatest
importance was assigned to pain/discomfort and anxiety/
depression [44]. Mulhern et al. [48], in their study using
DC modeling, observed that the attribute pain/discomfort
also showed the largest effect.
Table 1 Respondents’
characteristics
Characteristics EQ-5D-3L (N = 1824) EQ-5D-5L (N = 1874)
Male, n (%) 797 (44) 876 (47)
Age, years, mean (SD) 45.5 (14.3) 51.2 (13.4)
Age group, years, n (%)
18–24 101 (13) 74 (8)
25–34 90 (11) 47 (5)
35–44 134 (17) 95 (11)
45–54 214 (27) 172 (20)
Over 55 258 (32) 488 (56)
Female, n (%) 1,027 (56) 998 (53)
Age, years, mean (SD) 42.8 (13.8) 44.9 (15.1)
Age group, years, n (%)
18–24 145 (14) 179 (18)
25–34 175 (17) 108 (11)
35–44 192 (19) 121 (12)
45–54 276 (27) 224 (22)
Over 55 239 (23) 366 (37)
Diseases, n (%)
No diseases 701 (38) 705 (33)
Neck and back pain 440 (24) 459 (25)
Pain (abdomen, migraine, chronic) 231 (13) 208 (11)
Sleep problems 258 (141) 281 (15)
Fatigue 337 (19) 360 (19)
Diabetes mellitus 132 (7) 163 (9)
Heart disease 94 (5) 140 (7)
Hearing or vision loss 149 (8) 182 (10)
Asthma/COPD 177 (10) 163 (9)
Eczema 126 (7) 145 (8)
Mental health problems 171 (9) 179 (10)
Stroke 16 (1) 37 (2)
Rheumatism (osteoarthritis, arthritis) 186 (10) 195 (10)
Cancer 27 (2) 46 (2)
Epilepsy 20 (1) 14 (0.5)
Lung disease 38 (2) 37 (2)
Gastrointestinal disease 63 (4) 64 (3)
COPD chronic obstructive pulmonary disorder, SD standard deviation
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Table 2 Regression coefficients for the EQ-5D-3L and EQ-5D-5L based on a discrete choice model
EQ-5D-3L (the five attributes with their overall
weights)
b (SE) EQ-5D-5L (the five attributes with their overall
weights)
b (SE)
Mobility (0.248) Mobility (0.172)
No problems (level 1) Reference No problems (level 1) Reference
Some problems (level 2) - 0.323
(0.02)
Slight problems (level 2) - 0.138
(0.04)
Confined to bed (level 3) - 1.550
(0.03)
Moderate problems (level 3) - 0.290
(0.03)
Severe problems (level 4) - 0.968
(0.04)
Unable to (level 5) - 1.267
(0.04)
Self-care (0.146) Self-care (0.156)
No problems (level1) Reference No problems (level 1) Reference
Some problems (level 2) - 0.318
(0.02)
Slight problems (level 2) - 0.098
(0.04)
Unable to (level 3) - 1.044
(0.03)
Moderate problems (level 3) - 0.297
(0.03)
Severe problems (level 4) - 0.938
(0.04)
Unable to (level 5) - 1.123
(0.04)
Usual activities (0.178) Usual activities (0.175)
No problems (level 1) Reference No problems (level 1) Reference
Some problems (level 2) - 0.172
(0.02)
Slight problems (level 2) - 0.150
(0.04)
Unable to (level 3) - 1.055
(0.03)
Moderate problems (level 3) - 0.228
(0.03)
Severe problems (level 4) - 0.969
(0.03)
Unable to (level 5) - 1.302
(0.04)
Pain/discomfort (0.237) Pain/discomfort (0.237)
None (level 1) Reference None (level 1) Reference
Moderate (level 2) - 0.247
(0.02)
Slight* (level 2) - 0.076
(0.04)
Extreme (level 3) - 1.423
(0.03)
Moderate (level 3) - 0.262
(0.04)
Severe (level 4) - 1.150
(0.04)
Extreme (level 5) - 1.636
(0.04)
Anxiety/depression (0.191) Anxiety/depression (0.259)
None (level 1) Reference None (level 1) Reference
Moderate (level 2) - 0.379
(0.03)
Slight (level 2) - 0.253
(0.04)
Extreme (level 3) - 1.324
(0.03)
Moderate (level 3) - 0.543
(0.04)
Severe (level 4) - 1.347
(0.04)
Extreme (level 5) - 1.957
(0.04)
Log likelihood - 16979.542 Log likelihood - 16477.634
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Overall, we observed differences in the health-state
distributions for severe and mild/moderate states derived
from the EQ-5D-3L and EQ-5D-5L. Our findings are not in
line with those of Mulhern et al. [49], who observed the
opposite. However, it may be attributed to the fact that the
EQ-5D-3L UK value set has a larger range of values than
the EQ-5D-5L UK value set. In addition, the samples
analyzed in that study were recruited differently (England,
UK) and different valuation methods were used (TTO,
visual analog scale). Overall, the distributions of health
states in the current study showed a somewhat lower pro-
portion of severe states in the EQ-5D-5L than in the EQ-
5D-3L. These findings are not in line with the findings
published in the Dutch tariff [44], demonstrating the values
for all attainable health states to be higher in the 3L version
for the severe health states and higher for the 5L version for
Table 2 continued
EQ-5D-3L (the five attributes with their overall
weights)
b (SE) EQ-5D-5L (the five attributes with their overall
weights)
b (SE)
Wald Chi-square 4874.59 Wald Chi-square 5988.72
All variables were statistically significant at the 99% confidence level, p\ 0.01, except *p = 0.037
SE standard error
Table 3 Estimations for the EQ-5D-3L and EQ-5D-5L increments for consecutive levels
EQ-5D-3L b (SE) EQ-5D-5L b (SE)
Mobility Mobility
Some ? problems (level 2 ? level 1) 0.323 (0.02) Slight ? no problems (level 2 ? level 1) 0.138 (0.03)
Confined to bed ? some problems (level 3 ? level 2) 1.227 (0.03) Moderate ? slight problems (level 3 ? level 2) 0.152 (0.03)
Severe ? moderate problems (level 4 ? level 3) 0.678 (0.03)
Unable ? severe problems (level 5 ? level 4) 0.298 (0.03)
Self-care Self-care
Some ? no problems (level 2 ? level 1) 0.318 (0.02) Slight ? no problems (level 2 ? level 1) 0.098 (0.04)
Unable ? some problems (level 3 ? level 2) 0.726 (0.02) Moderate ? slight problems (level 3 ? level 2) 0.199 (0.04)
Severe ? moderate problems (level 4 ? level 3) 0.641 (0.04)
Unable ? severe problems (level 5 ? level 4) 0.185 (0.04)
Usual activities Usual activities
Some ? no problems (level 2 ? level 1) 0.172 (0.02) Slight ? no problems (level 2 ? level 1) 0.150 (0.04)
Unable ? some problems (level 3 ? level 2) 0.884 (0.03) Moderate ? slight problems* (level 3 ? level 2) 0.079 (0.04
Severe ? moderate problems (level 4 ? level 3) 0.741 (0.04)
Unable ? severe problems (level 5 ? level 4) 0.333 (0.04)
Pain/discomfort Pain/discomfort
Moderate ? none (level 2 ? level 1) 0.247 (0.02) Slight ? none* (level 2 ? level 1) 0.076 (0.04)
Extreme ? moderate (level 3 ? level 2) 1.176 (0.03) Moderate ? slight (level 3 ? level 2) 0.186 (0.04)
Severe ? moderate (level 4 ? level 3) 0.888 (0.04)
Extreme ? severe (level 5 ? level 4) 0.486 (0.03)
Anxiety/depression Anxiety/depression
Moderate ? none (level 2 ? level 1) 0.379 (0.03) Slight ? none (level 2 ? level 1) 0.253 (0.04)
Extreme ? moderate (level 3 ? level 2) 0.945 (0.02) Moderate ? slight (level 3 ? level 2) 0.289 (0.03)
Severe ? moderate (level 4 ? level 3) 0.804 (0.03)
Extreme ? severe (level 5 ? level 4) 0.610 (0.04)
All variables were statistically significant at the 99% confidence level, p\ 0.01, except *p\ 0.05
SE standard error
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moderate and mild health states (on the value range
0.35–0.75). Again, such a discrepancy may be caused by
differences in the conceptual and valuation approaches
used. The current study is based only on DC estimations,
while the Dutch tariff is based on the composite TTO and
tasks for valuing worse-than-death states were included. In
the Dutch tariff study, DC results were used to identify the
appropriate TTO modeling techniques, but not to estimate
health-state values.
The report by the National Institute for Health and Care
Excellence [50] suggested that the 5L instrument showed
higher mean utility scores than the 3L, meaning that the
improvements in health are slightly less in the 5L than in
the 3L, which results in interventions being considered as
less cost effective if based on the 5L. This may lead policy
makers to give due consideration to the choice of a version:
EQ-5D-5L may produce smaller benefits of innovations for
severe health states, according to our study, which may
discourage end users from using this version. These find-
ings raise challenges about the choice of the EQ-5D ver-
sion to be used: for particular interventions, end users are
likely to prefer the EQ-5D-3L, indicating higher benefits of
interventions. However, the studies included in the
National Institute for Health and Care Excellence docu-
ment are not based on valuations. In fact, the analysis
underlying that document used self-reported health
assessments scored according to the EQ-5D descriptive
system. Therefore, the comparison between the current
study and the study of the National Institute for Health and
Care Excellence should be taken with caution.
4.2 Limitations
It is worth mentioning the following limitation of our
study: there is a difference in the age group proportions of
the two samples. We tried to reach the comparability of the
representativeness and sample sizes for 3L and 5L ver-
sions; however, significant age differences were observed
according to the Chi-square test. One might argue that such
differences would bias the estimated results. However, an
additional analysis with inclusion of age groups as a sep-
arate predictor into the choice model did not reveal any
statistically significant effect of age on the estimated
coefficients.
By their nature, health-state values derived with choice
models cannot be interpreted as absolute (cardinal) num-
bers because of two reasons. First, the best health state (full
health) is dominant and cannot be used in the choice model
as an anchor. Second, the location of death is unknown
because a ‘death’ option was not included. Consequently,
DC models position health states on a scale between the
best and the worst health states. Therefore, one of the main
problems with choice models is normalizing its scale to a
death-full health (0.0–1.0) scale. To solve this problem, a
task extension or additional tasks should be included in the
design, such as death questions, duration on the health
states, or an accompanied TTO task. We did not use either
of these techniques. Instead, we used the published Dutch
A
B
Fig. 1 Frequency distribution of a all 243 EQ-5D-3L health-state
values and rescaled values; b all 3125 EQ-5D-5L health-state values
and rescaled values
Fig. 2 Kernel density plot for EQ-5D-3L and EQ-5D-5Lvalues
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valuation studies [43, 44] as an anchor for the values eli-
cited with the DC model. By doing so, the rescaling limi-
tation remains but anchor points are based in current
evidence.
Recent studies using different valuation frameworks for
quality-adjusted life-year calculations showed smaller dif-
ferences between the same health states in the EQ-5D-5L
version in comparison with the original EQ-5D-3L, which
raised concerns among end users (e.g., pharmaceutical
companies) [44, 49, 50]. In a recent UK study estimating a
value function for the EQ-5D-5L, the composite TTO was
introduced as a new valuation technique. That innovation is
a derivate of the conventional TTO based on a combination
of lead-time TTO [51] and standard TTO as used in the 3L.
This UK study applied a rescaling for the states ‘worse than
death’ (negative utilities) that differs from the rescaling
used in the original EQ-5D-3L [1]. In addition, the UK
study [52] analyzed TTO responses and DC responses
together in a hybrid model incorporating several other
analytical procedures (e.g., censoring, additional parameter
for heterogeneity of respondents, forcing consistency in
levels of attributes) [53]. Moreover, the authors of the
Dutch tariff [44] admitted that the similarities between the
EQ-5D-3L and EQ-5D-5L are not necessarily expected
owing to differences in the phrasing and valuation methods
used. Therefore, the divergence between the 3L and 5L
version, if based on the official EuroQol protocol, is likely
to be a combined effect of the differences in the way
individuals respond to the changed descriptive system and
because a totally new and different valuation framework
has been introduced [54]. The present study did not use a
TTO technique. Instead, we used DC for both versions of
EQ-5D, which resulted in certain differences in the weights
and overall distributions of the EQ-5D-3L and the EQ-5D-
5L health-state values.
Values derived with DC seem to be more robust and less
effected by possible framing effects, as the judgmental DC
task is more straightforward and simple than the TTO
variants. However, it needs to be stated that the design
strategy of selecting equal amount of DC pairs for both
versions may have had an impact on the estimated values.
Specifically, selecting 240 DC pairs for the EQ-5D-3L
would enable broader coverage of the health states than
selecting 240 pairs for the EQ-5D-5L because the EQ-5D-
5L comprises more health states.
Consequently, such a design setting would result in
more precise estimates for the EQ-5D-3L than for the EQ-
5D-5L. However, based on earlier studies [4, 44, 48],
having 240 pairs for the EQ-5D-5L is highly sufficient to
get precise estimates. Moreover, the standard deviations of
the coefficients, which reflect precision of an estimated
coefficient, showed that the difference is minor (the max-
imum standard deviation in the model for EQ-5D-3L is 0.3,
while the maximum standard deviation in the model for
EQ-5D-5L is 0.4).
4.3 Strengths
The present study has several strengths. First, a large rep-
resentative sample of the Dutch general population has
been achieved. Second, it used the same valuation method
(DC) and the same statistical analysis for both EQ-5D
versions. Third, an efficient design was applied to maxi-
mize the precision of estimated regression coefficients,
while respondent fatigue was prevented by applying a two-
level overlap. Overall, this is the first head-to-head DC
study to compare health-state values derived from EQ-5D-
3L and EQ-5D-5L using large samples.
5 Conclusion
The distributions of health states suggested that the pro-
portion of severe health states with low values in the EQ-
5D-5L was slightly higher than in the EQ-5D-3L, and the
proportion of mild/moderate states was lower in the EQ-
5D-5L than in the EQ-5D-3L. Additionally, the overall
weights of the attributes in the EQ-5D-3L and the EQ-5D-
5L are different. We suggest that even small differences in
the phrasing of the descriptive system or in the valuation
protocol may affect individual responses and thereby the
elicited values. Finally, it needs to be emphasized that the
applied valuation framework in combination with particu-
lar statistical models used to estimate the weights for the
attributes and their levels may explain the substantial dis-
crepancies between the 3L and 5L observed in earlier
studies.
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